KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Shares Outstanding (Weighted Average): 2017-2025

Historic Shares Outstanding (Weighted Average) for Elanco Animal Health (ELAN) over the last 8 years, with Sep 2025 value amounting to $496.8 million.

  • Elanco Animal Health's Shares Outstanding (Weighted Average) rose 0.50% to $496.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $496.8 million, marking a year-over-year increase of 0.50%. This contributed to the annual value of $494.4 million for FY2024, which is 0.32% up from last year.
  • Elanco Animal Health's Shares Outstanding (Weighted Average) amounted to $496.8 million in Q3 2025, which was up 0.03% from $496.6 million recorded in Q2 2025.
  • Elanco Animal Health's Shares Outstanding (Weighted Average)'s 5-year high stood at $496.8 million during Q3 2025, with a 5-year trough of $472.2 million in Q1 2021.
  • In the last 3 years, Elanco Animal Health's Shares Outstanding (Weighted Average) had a median value of $494.2 million in 2024 and averaged $494.0 million.
  • Data for Elanco Animal Health's Shares Outstanding (Weighted Average) shows a peak YoY grew of 18.58% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Elanco Animal Health's Shares Outstanding (Weighted Average) stood at $473.1 million in 2021, then increased by 0.23% to $474.2 million in 2022, then climbed by 3.92% to $492.8 million in 2023, then grew by 0.32% to $494.4 million in 2024, then increased by 0.50% to $496.8 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $496.8 million in Q3 2025, compared to $496.6 million in Q2 2025 and $494.6 million in Q1 2025.